
[ Mon, Oct 12th 2009 ] - Market Wire

[ Fri, Oct 09th 2009 ] - Market Wire
[ Fri, Oct 09th 2009 ] - Market Wire
[ Fri, Oct 09th 2009 ] - Market Wire
[ Fri, Oct 09th 2009 ] - Market Wire
[ Fri, Oct 09th 2009 ] - Market Wire
[ Fri, Oct 09th 2009 ] - Market Wire

[ Thu, Oct 08th 2009 ] - Market Wire
[ Thu, Oct 08th 2009 ] - Market Wire
[ Thu, Oct 08th 2009 ] - Market Wire
[ Thu, Oct 08th 2009 ] - Market Wire
[ Thu, Oct 08th 2009 ] - Market Wire
[ Thu, Oct 08th 2009 ] - Market Wire

[ Wed, Oct 07th 2009 ] - Market Wire
[ Wed, Oct 07th 2009 ] - Market Wire
[ Wed, Oct 07th 2009 ] - Market Wire
[ Wed, Oct 07th 2009 ] - Market Wire
[ Wed, Oct 07th 2009 ] - Market Wire
[ Wed, Oct 07th 2009 ] - Market Wire

[ Tue, Oct 06th 2009 ] - Market Wire
[ Tue, Oct 06th 2009 ] - Market Wire
[ Tue, Oct 06th 2009 ] - Market Wire
[ Tue, Oct 06th 2009 ] - Market Wire
[ Tue, Oct 06th 2009 ] - Market Wire
[ Tue, Oct 06th 2009 ] - Market Wire

[ Mon, Oct 05th 2009 ] - Market Wire
[ Mon, Oct 05th 2009 ] - Market Wire
[ Mon, Oct 05th 2009 ] - Market Wire
[ Mon, Oct 05th 2009 ] - Market Wire
[ Mon, Oct 05th 2009 ] - Market Wire
[ Mon, Oct 05th 2009 ] - Market Wire

[ Sun, Oct 04th 2009 ] - Market Wire

[ Fri, Oct 02nd 2009 ] - Market Wire
[ Fri, Oct 02nd 2009 ] - Market Wire
[ Fri, Oct 02nd 2009 ] - Market Wire
[ Fri, Oct 02nd 2009 ] - Market Wire
[ Fri, Oct 02nd 2009 ] - Market Wire

[ Thu, Oct 01st 2009 ] - Market Wire
[ Thu, Oct 01st 2009 ] - Market Wire
[ Thu, Oct 01st 2009 ] - Market Wire
[ Thu, Oct 01st 2009 ] - Market Wire
[ Thu, Oct 01st 2009 ] - Market Wire

[ Wed, Sep 30th 2009 ] - Market Wire
[ Wed, Sep 30th 2009 ] - Market Wire
[ Wed, Sep 30th 2009 ] - Market Wire
[ Wed, Sep 30th 2009 ] - Market Wire
[ Wed, Sep 30th 2009 ] - Market Wire

[ Tue, Sep 29th 2009 ] - Market Wire
[ Tue, Sep 29th 2009 ] - Market Wire
[ Tue, Sep 29th 2009 ] - Market Wire
[ Tue, Sep 29th 2009 ] - Market Wire
[ Tue, Sep 29th 2009 ] - Market Wire

[ Mon, Sep 28th 2009 ] - Market Wire
[ Mon, Sep 28th 2009 ] - Market Wire
[ Mon, Sep 28th 2009 ] - Market Wire
[ Mon, Sep 28th 2009 ] - Market Wire
[ Mon, Sep 28th 2009 ] - Market Wire

[ Fri, Sep 25th 2009 ] - Market Wire
[ Fri, Sep 25th 2009 ] - Market Wire
[ Fri, Sep 25th 2009 ] - Market Wire
[ Fri, Sep 25th 2009 ] - Market Wire
[ Fri, Sep 25th 2009 ] - Market Wire

[ Thu, Sep 24th 2009 ] - Market Wire
[ Thu, Sep 24th 2009 ] - Market Wire
[ Thu, Sep 24th 2009 ] - Market Wire
[ Thu, Sep 24th 2009 ] - Market Wire
[ Thu, Sep 24th 2009 ] - Market Wire

[ Wed, Sep 23rd 2009 ] - Market Wire
[ Wed, Sep 23rd 2009 ] - Market Wire
[ Wed, Sep 23rd 2009 ] - Market Wire
[ Wed, Sep 23rd 2009 ] - Market Wire
[ Wed, Sep 23rd 2009 ] - Market Wire

[ Tue, Sep 22nd 2009 ] - Market Wire
[ Tue, Sep 22nd 2009 ] - Market Wire
[ Tue, Sep 22nd 2009 ] - Market Wire
[ Tue, Sep 22nd 2009 ] - Market Wire
[ Tue, Sep 22nd 2009 ] - Market Wire

[ Mon, Sep 21st 2009 ] - Market Wire
[ Mon, Sep 21st 2009 ] - Market Wire
[ Mon, Sep 21st 2009 ] - Market Wire
[ Mon, Sep 21st 2009 ] - Market Wire
[ Mon, Sep 21st 2009 ] - Market Wire

[ Fri, Sep 18th 2009 ] - Market Wire
[ Fri, Sep 18th 2009 ] - Market Wire
[ Fri, Sep 18th 2009 ] - Market Wire

[ Thu, Sep 17th 2009 ] - Market Wire
[ Thu, Sep 17th 2009 ] - Market Wire
[ Thu, Sep 17th 2009 ] - Market Wire
[ Thu, Sep 17th 2009 ] - Market Wire
[ Thu, Sep 17th 2009 ] - Market Wire

[ Wed, Sep 16th 2009 ] - Market Wire
[ Wed, Sep 16th 2009 ] - Market Wire
[ Wed, Sep 16th 2009 ] - Market Wire
[ Wed, Sep 16th 2009 ] - Market Wire
[ Wed, Sep 16th 2009 ] - Market Wire

[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire

[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire

[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire

[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire

[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire

[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire

[ Sun, Sep 06th 2009 ] - Market Wire

[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire

[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire

[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire

[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire

[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire

[ Fri, Aug 28th 2009 ] - Market Wire
[ Fri, Aug 28th 2009 ] - Market Wire
[ Fri, Aug 28th 2009 ] - Market Wire

[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire

[ Wed, Aug 26th 2009 ] - Market Wire
[ Wed, Aug 26th 2009 ] - Market Wire
[ Wed, Aug 26th 2009 ] - Market Wire
[ Wed, Aug 26th 2009 ] - Market Wire

[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire

[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire

[ Sun, Aug 23rd 2009 ] - Market Wire

[ Fri, Aug 21st 2009 ] - Market Wire
[ Fri, Aug 21st 2009 ] - Market Wire
[ Fri, Aug 21st 2009 ] - Market Wire

[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire

[ Wed, Aug 19th 2009 ] - Market Wire
[ Wed, Aug 19th 2009 ] - Market Wire
[ Wed, Aug 19th 2009 ] - Market Wire
[ Wed, Aug 19th 2009 ] - Market Wire

[ Tue, Aug 18th 2009 ] - Market Wire
[ Tue, Aug 18th 2009 ] - Market Wire
[ Tue, Aug 18th 2009 ] - Market Wire

[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire

[ Sun, Aug 16th 2009 ] - Market Wire

[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
ConjuChem Announces Fiscal 2009 Third Quarter Financial Results
//health-fitness.news-articles.net/content/2009/ .. fiscal-2009-third-quarter-financial-results.html
Published in Health and Fitness on Monday, September 14th 2009 at 14:06 GMT by Market Wire
Published in Health and Fitness on Monday, September 14th 2009 at 14:06 GMT by Market Wire

ConjuChem Biotechnologies Inc. UNAUDITED INTERIM BALANCE SHEETS As at July 31, October 31, 2009 2008 $ $ ---------------------------- ASSETS Current Cash and cash equivalents 600,239 2,187,423 Investments 3,704,941 18,934,737 Accounts receivable 1,013,069 160,644 Investment tax credits receivable 680,000 542,000 Prepaid expenses 278,195 229,006 ---------------------------- Total current assets 6,276,444 22,053,810 Property, plant and equipment 677,072 841,685 Intangible assets 6,942 11,108 Other assets 653,325 - ---------------------------- 7,613,783 22,906,603 ---------------------------- ---------------------------- LIABILITIES AND SHAREHOLDERS' DEFICIENCY Current liabilities Accounts payable and accrued liabilities 3,803,428 10,080,463 ---------------------------- Total current liabilities 3,803,428 10,080,463 Convertible unsecured subordinated debentures 15,767,248 13,634,906 ---------------------------- 19,570,676 23,715,369 ---------------------------- Shareholders' deficiency Capital stock 266,858,635 266,823,735 Warrants 10,817,394 10,817,394 Equity portion of convertible unsecured subordinated debentures 5,184,867 5,193,793 Contributed surplus 50,893,422 48,818,826 Deficit (345,711,211) (332,390,857) Accumulated other comprehensive loss - (71,657) ---------------------------- Total shareholders' deficiency (11,956,893) (808,766) ---------------------------- 7,613,783 22,906,603 ---------------------------- ---------------------------- ConjuChem Biotechnologies Inc. UNAUDITED INTERIM STATEMENTS OF DEFICIT Three-months ended Nine-months ended July 31, July 31, July 31, July 31, 2009 2008 2009 2008 $ $ $ $ -------------------------------------------------------- Deficit, beginning of period (344,298,290) (312,739,566) (332,390,857) (292,973,699) Net loss for the period (1,412,921) (8,736,726) (13,320,354) (28,502,593) -------------------------------------------------------- Deficit, end of period (345,711,211) (321,476,292) (345,711,211) (321,476,292) -------------------------------------------------------- -------------------------------------------------------- ConjuChem Biotechnologies Inc. UNAUDITED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three-months ended Nine-months ended July 31, July 31, July 31, July 31, 2009 2008 2009 2008 $ $ $ $ -------------------------------------------------------- REVENUES Contract revenues 13,589 8,827 29,032 60,731 Interest income 15,772 306,076 154,289 1,254,657 -------------------------------------------------------- 29,361 314,903 183,321 1,315,388 -------------------------------------------------------- EXPENSES Research and development 1,532,858 6,153,681 8,597,138 15,233,963 Investment tax credits (1,467,174) (100,000) (2,797,174) (300,000) -------------------------------------------------------- Net research and development expenses 65,684 6,053,681 5,799,964 14,933,963 General and administrative expenses (452,509) 1,198,403 2,058,651 3,996,354 Amortization of property, plant and equipment 39,882 55,411 124,568 165,511 Amortization of intangible assets 1,389 2,462 4,166 7,386 Stock-based compensation 681,835 643,099 2,074,596 2,015,937 Financial charges 2,434 2,987 11,331 13,294 Foreign exchange loss (gain) (62,125) 60,543 55,167 251,818 Accretion in carrying value of convertible senior unsecured notes and interest - - - 5,504,427 Accretion in carrying value of convertible unsecured subordinated debentures and interest 1,165,692 1,035,043 3,375,232 2,661,852 Loss on redemption of long-term investments - - - 267,439 -------------------------------------------------------- 1,442,282 9,051,629 13,503,675 29,817,981 -------------------------------------------------------- Net loss for the period (1,412,921) (8,736,726) (13,320,354) (28,502,593) OTHER COMPREHENSIVE INCOME (LOSS) Unrealized gain/ (loss) on investments (528) (17,631) 71,657 (14,899) -------------------------------------------------------- Comprehensive loss for the period (1,413,449) (8,754,357) (13,248,697) (28,517,492) -------------------------------------------------------- -------------------------------------------------------- Basic and diluted loss per share (0.01) (0.04) (0.05) (0.12) -------------------------------------------------------- -------------------------------------------------------- Weighted average number of common shares outstanding during the period 250,432,418 246,094,442 250,514,149 242,188,235 -------------------------------------------------------- -------------------------------------------------------- ConjuChem Biotechnologies Inc. UNAUDITED INTERIM STATEMENTS OF CASH FLOWS Three-months ended Nine-months ended July 31, July 31, July 31, July 31, 2009 2008 2009 2008 $ $ $ $ -------------------------------------------------------- OPERATING ACTIVITIES Net loss (1,412,921) (8,736,726) (13,320,354) (28,502,593) Items not affecting cash: Amortization of property, plant and equipment 39,882 55,411 124,568 165,511 Amortization of intangible assets 1,389 2,462 4,166 7,386 Amortization of premium on long-term investments - - - (8,436) Stock-based compensation 681,835 643,099 2,074,596 2,015,937 Accretion in carrying value of convertible senior unsecured notes and interest - - - 5,504,427 Accretion in carrying value of convertible unsecured subordinated debentures 749,064 672,613 2,158,316 1,630,769 Gain on proceeds from sales of property, plant and equipment (4,019) - (9,272) - Loss on redemption of long-term investments - - - 267,439 -------------------------------------------------------- 55,230 (7,363,141) (8,967,980) (18,919,560) Net changes in non-cash working capital balances relating to operations (3,777,978) (63,878) (7,316,649) 462,379 -------------------------------------------------------- Cash flows relating to operating activities (3,722,748) (7,427,019) (16,284,629) (18,457,181) -------------------------------------------------------- INVESTING ACTIVITIES Acquisition of investments (1,221,596) (6,137,130) (10,264,700) (27,832,011) Proceeds on maturities of investments 3,488,708 15,823,221 25,566,153 37,338,629 Acquisition long-term investments - - - (167,037) Proceeds on redemption of long-term investments - - - 59,644,132 Acquisition of property, plant and equipment (1,486) (1,318) (13,138) (11,090) Proceeds from sales of property, plant and equipment 21,065 - 62,455 - Acquisition of intangible assets - - - (1,179) -------------------------------------------------------- Cash flows relating to investing activities 2,286,691 9,684,773 15,350,770 68,971,444 -------------------------------------------------------- FINANCING ACTIVITIES Repayment of convertible senior unsecured notes - - - (58,006,914) Issuance of convertible unsecured subordinated debentures - - - 22,000,000 Issuance costs paid in cash - - - (1,764,414) Increase in other assets (653,325) - (653,325) - -------------------------------------------------------- Cash flows relating to financing activities (653,325) - (653,325) (37,771,328) -------------------------------------------------------- Net change in cash and cash equivalents during the period (2,089,382) 2,257,754 (1,587,184) 12,742,935 Cash and cash equivalents, beginning of period 2,689,621 11,720,885 2,187,423 1,235,704 -------------------------------------------------------- Cash and cash equivalents, end of period 600,239 13,978,639 600,239 13,978,639 -------------------------------------------------------- -------------------------------------------------------- Supplemental cash flow information: Interest paid 912,568 892,926 1,727,229 13,899,840 --------------------------------------------------------
Publication Contributing Sources
Similar Health and Fitness Publications
[ Thu, Sep 10th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Wed, Aug 05th 2009 ] - Market Wire
[ Thu, Jun 11th 2009 ] - Market Wire
[ Mon, May 18th 2009 ] - Market Wire
[ Mon, Apr 13th 2009 ] - Market Wire
[ Mon, Feb 23rd 2009 ] - Market Wire